Please login to the form below

Not currently logged in
Email:
Password:

Clinicians key to delivering QIPP

Survey shows UK doctors believe a practical approach is essential to improving patient care with limited funds

The results of a survey of over 600 doctors from across the UK reveal the extent to which comprehensive engagement with clinicians will be key to the success of the NHS' QIPP (quality, innovation, productivity and prevention) programme.

The survey, conducted by Doctors.net.uk in February and March, reveals a widespread lack of understanding about the QIPP agenda and the aim to improve both quality patient outcomes and productivity. For example, four in ten clinicians (42 per cent) have not yet heard of QIPP and its reframing of strategic objectives, neither have they been exposed to its specific underlying themes around improving patient care and measurable cost savings.

Of those doctors that knew about QIPP, nine out of ten (87 per cent) do not yet view its introduction as something that will make a positive difference to healthcare.

Dr Tim Ringrose, medical director at Doctors.net.uk, said: "Doctors are passionate about improving patient care, and believe they have a real role in how to redesign care pathways to drive the improvement and efficiencies. The NHS needs to involve and engage clinicians directly in the process and quickly to help meet the financial constraints.

"It obviously requires high levels of cooperation between managers and clinicians to harness innovative methods and changes in working practices, especially in the priority care pathways, such as diabetes, mental health, coronary heart disease and cancer care. Doctors traditionally respond poorly to top-down initiatives; they would much rather be instrumental in designing and implementing localised solutions.

"While the sentiment unearthed by our survey is clear, there is a significant opportunity to harness innovative online engagement channels that have the proven capability to influence clinical behaviour en masse in shorter timeframes than traditional methods and channels."

13th April 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics